Quimioterapia Adjuvante no Câncer da Mama
DOI:
https://doi.org/10.32635/2176-9745.RBC.1985v31n2.3320Palabras clave:
Câncer da Mama, Quimioterapia AdjuvanteResumen
Os autores fazem uma análise retrospectiva dos resultados do tratamento quimioterápico adjuvante em 95 pacientes com carcinoma da mama. As pacientes foram estratificadas pelo status patológico dos linfonodos axilares: grupo A com 1-3 linfonodos positivos e grupo B com mais de 3 linfonodos positivos. Aos 60 meses a probabilidade de sobrevida foi de 86,1% para o grupo A e de 83% para o B (p=0.042), a probabilidade de sobrevida sem doença foi de 86,1% no A e 64,4% no B (p<0.001). Em 49 pacientes acompanhadas por mais de 2 anos e avaliadas aos 24 meses a sobrevida foi de 95,4% no grupo A e de 85,1% no B (p=0.014), a sobrevida sem doença de 86,3% no A e de 66,6% no B (p=0.415). As pacientes que receberam 85% ou mais da dose prevista apresentaram 23,4% de recidivas e naquelas com doses menores foi de 45%. As recidivas locais foram semelhantes nas pacientes com e sem radioterapia. É feita uma comparação dos resultados obtidos com o estudo de Milão.
Descargas
Citas
Adjuvant Chemotherapy of breast cancer. Summary of na NIH consensus statement. Bri Med J 281: 724-725, 1980. DOI: https://doi.org/10.1136/bmj.281.6242.724
Ahmann, D.: Status of adjuvant chemotherapy in patients with breast cancer. Cancer, 53: 724-728, 1984. DOI: https://doi.org/10.1002/1097-0142(19840201)53:3+<724::AID-CNCR2820531321>3.0.CO;2-8
Bedwinek, J.: Adjuvant irradiation for early breast cancer. Cancer, 53: 729-739, 1984. DOI: https://doi.org/10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R
Bonadonna, G. et al.: Combination Chemotherapy as an adjuvante treatment in operable breast cancer. N EngI J Med, 294: 405-410, 1976. DOI: https://doi.org/10.1056/NEJM197602192940801
Bonadonna, G. et al.: The CMF program for operable breast cancer with positive axiliary nodes. Cancer, 39: 2904-2915, 1977. DOI: https://doi.org/10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8
Bonadonna, G. et al.: Are surgical adjuvant trials altering the course of breast cancer? Seminars in Oncol vol. 5, n? 4: 450-464, 1978.
Bonadonna, G. et al.: Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med, 304: 10-15, 1981. DOI: https://doi.org/10.1056/NEJM198101013040103
Carpenter, J. et al.: Favorabie factors in the adjuvant therapy of breast cancer. Câncer, 50: 18-23, 1982. DOI: https://doi.org/10.1002/1097-0142(19820701)50:1<18::AID-CNCR2820500105>3.0.CO;2-J
Chu, A. et al.: Comparasion of adjuvant postoperative radiotherapy and multiple-drug chemotherapy (CMF—VP) in operable breast cancer patients with more than four positive axiliary lymphnodes. Cancer, 50: 212-218, 1982, DOI: https://doi.org/10.1002/1097-0142(19820715)50:2<212::AID-CNCR2820500208>3.0.CO;2-V
Cowan, K. et al.: Recent progress in breast cancer management. Arch Intern Med, 141: 1055-1059, 1981. DOI: https://doi.org/10.1001/archinte.141.8.1055
Fisher, B. et al.: L-phenylaianine mustard (L—PAM) in the management of primary breast cancer. Cancer, 39: 2883-2903, 1977. DOI: https://doi.org/10.1002/1097-0142(197706)39:6<2883::AID-CNCR2820390676>3.0.CO;2-9
Fisher, E. et al.: Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (Protocol n° 4). Cancer, 53: 712-723, 1984. DOI: https://doi.org/10.1002/1097-0142(19840201)53:3+<712::AID-CNCR2820531320>3.0.CO;2-I
Harris, J. et al.: The role of radiation therapy in the primary treatment of carcinoma of the breast. Seminars in Oncol vol. 5, n° 4: 403-416, 1978.
Harris, J. et al.: Primary radiation therapy for early breast cancer. Cancer, 52: 2547-2552, 1983. DOI: https://doi.org/10.1002/1097-0142(19830615)51:12+<2547::AID-CNCR2820511328>3.0.CO;2-#
Henderson, C.: Chemotherapy of breast cancer. Cancer, 51: 2553-2559, 1983. DOI: https://doi.org/10.1002/1097-0142(19830615)51:12+<2553::AID-CNCR2820511329>3.0.CO;2-7
Kinne, D.: Surgical management of primary breast cancer. Cancer, 51: 2540-2546, 1983. DOI: https://doi.org/10.1002/1097-0142(19830615)51:12+<2540::AID-CNCR2820511327>3.0.CO;2-N
Mouridsen, H. et al.: Adjuvant systemic therapy in breast cancer; a review. Eur J Cancer Clin Oncol, vol. 19, n° 12: 1753-1770, 1983. DOI: https://doi.org/10.1016/0277-5379(83)90164-5
Stenkvist, B. et al.: Predicting breast cancer recurrence. Cancer, 50: 2884-2893, 1982. DOI: https://doi.org/10.1002/1097-0142(19821215)50:12<2884::AID-CNCR2820501231>3.0.CO;2-K
Veronesi, U. et al.: Conservative treatment of breast cancer. Cancer, 39: 2822-2826, 1977. DOI: https://doi.org/10.1002/1097-0142(197706)39:6<2822::AID-CNCR2820390670>3.0.CO;2-#
Veronesi, U.: Value of limited surgery for breast cancer. Seminars in Oncol vol. 5, n° 4: 395-402, 1978.
